KVAC logo

KEEN VISION ACQUISITION CORP

KVACNASDAQ
πŸ† #4029 by market capUS Equity
$11.51β–Ό $0.37 (βˆ’3.20%)
Live
1hβ€”
24hβ–Ό 3.2%
7dβ–Ό 2.6%
14dβ–Ό 2.6%
30dβ–Ό 2.6%
1yβ–² 2.3%
🏦Market Cap
$63M
Small Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
β€”
Otter Score
45
Weak

Trading Snapshot

Day Range
$11.39 – $11.73
52-Week Range
$11.00 – $18.72
Volume
$2.80B
Avg Volume
$2.10B
Shares Outstanding
5.5M
Next Earnings
Oct 13, 2026

Fundamentals Snapshot

Annual Revenue
$5M
Last Q Revenue
$1M
P/E Ratio
44.2
P/S Ratio
β€”
EPS (TTM)
$0.15
Dividend Yield
β€”

Why Investors Own KVAC

  • βœ“High-growth profile β€” revenue up +2.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 70% gross margin and 11% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$5Mβ–² +4.6% YoY
Gross Margin (TTM)
69.5%β–Ό βˆ’0.5% YoY
Operating Income (TTM)
$684,534β–² +4.6% YoY
Free Cash Flow (TTM)
$558,701β–² +4.6% YoY

About KEEN VISION ACQUISITION CORP

Keen Vision Acquisition Corporation (KVAC) is a firm founded with the primary objective of finalizing a substantial business transaction. This could involve, but is not limited to, a merger, an equity exchange, an asset acquisition, a share purchase, a capital reordering, or a corporate restructuring, with one or more external entities. KVAC strategically concentrates its efforts on identifying and collaborating with companies operating within the biotechnology, consumer product, and agricultural industries. The enterprise was formally established in 2021 and maintains its principal office in Summit, New Jersey.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
45/100

Analyst Price Target

β“˜
Average Target
$13.36
β–² +16.1% Upside
High Target$14.58
Low Target$10.32
Based on 33 analysts

Latest News & Updates